Medication history-wide association studies for pharmacovigilance of pregnant patients.

Challa, Anup P; Niu, Xinnan; Garrison, Etoi A; Van Driest, Sara L; Bastarache, Lisa M; Lippmann, Ethan S; Lavieri, Robert R; Goldstein, Jeffery A; Aronoff, David M

Challa, Anup P; Niu, Xinnan; Garrison, Etoi A; Van Driest, Sara L; Bastarache, Lisa M; Lippmann, Ethan S; Lavieri, Robert R; Goldstein, Jeffery A; Aronoff, David M.

Afiliação

Challa AP; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN 37203 USA.
Niu X; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212 USA.
Garrison EA; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115 USA.
Van Driest SL; Department of Biomedical Informatics, Vanderbilt University, Nashville, TN 37203 USA.
Bastarache LM; Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN 37203 USA.
Lippmann ES; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232 USA.
Lavieri RR; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203 USA.
Goldstein JA; Department of Biomedical Informatics, Vanderbilt University, Nashville, TN 37203 USA.
Aronoff DM; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212 USA.

Commun Med (Lond) ; 2: 115, 2022.

Article em En | MEDLINE | ID: mdl-36124058

Palavras-chave

Adverse effects; Drug development

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Commun Med (Lond) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google